TScan Therapeutics, Inc is a clinical-stage biopharmaceutical company based in Waltham, MA, dedicated to revolutionizing cancer treatment by discovering new cancer targets and developing safe and effective T cell therapies for patients.
With a unique therapeutic approach that draws insights from patients who have successfully fought cancer, TScan aims to unleash the untapped potential of the human immune system, creating life-changing T cell therapies that have the potential to transform the lives of patients.
Generated from the website